Copart Begins $10.50-a-Share Cash Tender Offer for ACV Auctions, Valuing It at About $1.9 Billion

A $10.50 Offer, Measured From Two Different Starting Lines

A Copart subsidiary called Apple Merger Sub started buying up shares of ACV Auctions on September 17, 2026, offering $10.50 in cash for each one^[1][4]. That values the whole company at about $1.9 billion^[3]. Both companies' boards signed off on the deal unanimously, and ACV's board is telling its own shareholders to take the money^[2][3].

The offer runs until one minute after 11:59 p.m. Eastern on September 30, unless Copart extends it^[1]. It's an all-cash deal, paid from Copart's own bank account, with no financing condition attached — meaning Copart can't walk away later by claiming the money fell through^[1][3]. The only real hurdle left is antitrust review: federal regulators get a mandatory waiting period to look at the deal before it can close^[1][3].

Here's the tension nobody disputes and everybody reads differently. Copart and ACV's board call $10.50 a 45% premium over ACV's last trading price before a sale became public knowledge^[3][5]. Plaintiffs' lawyers call the same $10.50 a steep markdown from the $37.77 ACV once traded at, back in 2021^[9][10][11]. Both numbers are real. They're just measured from different starting lines.

What a Tender Offer Actually Does

Most big buyouts go through a shareholder vote. This one skips that step. Copart is instead asking ACV's shareholders to hand over — "tender" — their shares directly for cash^[1].

Once a majority of ACV's outstanding shares are tendered and paid for, Copart folds ACV into itself. Any shareholders who didn't tender get cashed out later, at the same $10.50 price, through a follow-on merger^[1]. It's generally faster than the vote-based route, which is part of why Copart chose it.

The one thing that isn't in Copart's control is antitrust clearance. Under the Hart-Scott-Rodino Act, large mergers have to sit with the Federal Trade Commission and the Justice Department for a set waiting period before they can close, so regulators get a first look^[1][3]. As of this writing, no agency has said it's challenging the deal^[16]. If the waiting period runs out clean, the companies expect to close by the end of 2026^[3].

Two Halves of the Same Industry, Now Under One Roof

Copart's core business is auctioning wrecked and total-loss cars for insurance companies. ACV runs something different: an online marketplace where dealers buy and sell drivable used cars from other dealers, with condition checks done digitally^[3][18]. Put together, Copart says, it now touches a car's whole life, from a dealer trade-in to a total-loss wreck^[3][18].

That pitch sits on top of a real problem for Copart. Insurers have been repairing more damaged cars instead of writing them off, and some drivers have cut back on coverage. Both trends mean fewer wrecked cars flow into Copart's salvage auctions^[17]. Buying ACV gives Copart a growth line that doesn't depend on crash volume^[15].

ACV had its own pressure pushing toward a sale. It's a growing company that never built thick profit margins, and the stock market punished it hard for that in February 2026, when its guidance for the year came in below what Wall Street expected^[12]. Its shares had already fallen 47% over the prior year by the time the sale talks became public^[5]. A board in that position has a real incentive to lock in cash now rather than gamble on a turnaround.

The Same Company, Read Through Two Price Tags

ACV's board frames this as a strong outcome from a real sale process. The company drew takeover interest in August, worked with financial advisers, and landed an all-cash offer roughly 45% above the last price before that interest went public^[3][5]. In a market where ACV's stock had already lost nearly half its value in a year, the board's argument is that certainty beat waiting^[5].

Several plaintiffs'-side law firms — including Ademi LLP and Kahn Swick & Foti — see it differently. They've announced investigations into whether $10.50 actually shortchanges ACV shareholders and whether the board ran a fair process^[9][10]. Their strongest evidence is ACV's own history: the company went public in March 2021 at $25 a share, hit $37.77 within weeks, and has never gotten close to that price since^[11]. Announcing an "investigation" is close to standard practice for these firms after any big buyout — they operate on contingency fees and file similar notices on most public-company deals — so the announcement by itself isn't proof of wrongdoing, but the underlying price gap is real^[9][10].

There's a third, quieter angle that most U.S. business coverage skipped. ACV had itself sued Manheim, ADESA, and the industry's trade association in 2022, alleging they blocked ACV from a shared vehicle-tracking system called AutoIMS to keep it from competing fairly; that case was settled in October 2024 and isn't an active dispute anymore^[13][14][20]. What is still open is the separate question of whether regulators will look hard at one large auction company absorbing a major rival platform, even one serving a different set of sellers^[13][14][16]. A London-based regulatory trade outlet, MLex, was one of the few publications to center its coverage on that antitrust question rather than the price^[16].

What the Coverage Left Out, By Audience

Financial outlets aimed at U.S. retail investors, like The Motley Fool, wrote the story from Copart's strategic point of view — what Copart is really buying and why it makes sense for Copart's growth^[15]. That framing is accurate as far as it goes, but it leaves out the question of whether ACV's own shareholders were well served by the price. Insurance Journal, writing for an insurer audience, leaned into Copart's volume squeeze as the deal's real driver, which is true but frames the purchase as defensive rather than opportunistic^[17].

Bloomberg broke both the initial sale-exploration report in August and the near-final-deal report in September, sourced to unnamed insiders in both cases^[5][6]. Its own August reporting is what created the "unaffected" stock price that both Copart and the plaintiffs' firms now use as their reference point — coverage that became part of the deal's own math^[3][5]. RTTNews stuck closest to a plain restatement of the SEC filings, with price and deadline and little else, though even that framing passes along the company's premium figures without the longer price history that gives them context^[8].

The most one-sided item in the mix isn't really news coverage at all. A PR Newswire release headlined "ACV SHAREHOLDER ALERT" is a solicitation from Ademi LLP, formatted to read like a news story but written to recruit clients for a lawsuit^[9]. It raises a legitimate question about the deal's price, but the format itself is advertising.

What Happens Next

Shareholders who tender their shares are set to get $10.50 in cash by early October, assuming the offer's conditions are met^[1]. The two moving pieces left are whether enough shares get tendered and whether the antitrust waiting period clears without a second request for more documents from regulators^[1][3][16]. A second request would push the closing well past the end of 2026 and could force Copart to extend its September 30 deadline^[1][16].

One detail sits outside every side's framing. ACV put itself up for sale after takeover interest arrived in August, and no rival bidder has surfaced publicly since^[5]. That could mean $10.50 is simply what the market was willing to pay. Or it could mean the process wrapped up before a competing offer had time to appear. Nothing due by September 30 will settle which one it was.